Bujamin Vokshi
@vokshib.bsky.social
François Wallace Monahan Fellow, MSKCC (NYC). Previously Johns Hopkins 🇺🇸 and IGBMC 🇫🇷. Views my own.
Reposted by Bujamin Vokshi
So happy our paper on TFE3 fusion oncoprotein condensates in translocation RCC is online at Cell Reports! Great collaboration from Eneda Toska, Vito Rebecca, Marston Linehan and Hongkai Ji labs. Proud of the work of trainees Choon Leng So, Jane Lee, Bujamin Vokshi et al www.cell.com/cell-reports...
TFE3 fusion oncoprotein condensates drive transcriptional reprogramming and cancer progression in translocation renal cell carcinoma
So et al. investigate TFE3 fusion oncoproteins (FOs) in translocation renal cell carcinoma
(tRCC) and find that TFE3 FOs form transcriptional condensates and drive tRCC progression.
The structured coi...
www.cell.com
April 16, 2025 at 2:23 PM
So happy our paper on TFE3 fusion oncoprotein condensates in translocation RCC is online at Cell Reports! Great collaboration from Eneda Toska, Vito Rebecca, Marston Linehan and Hongkai Ji labs. Proud of the work of trainees Choon Leng So, Jane Lee, Bujamin Vokshi et al www.cell.com/cell-reports...
Reposted by Bujamin Vokshi
Harvard has set an example for other higher-ed institutions - rejecting an unlawful and ham-handed attempt to stifle academic freedom, while taking steps to make sure students can benefit from an environment of intellectual inquiry, rigorous debate and mutual respect. Let’s hope others follow suit.
April 15, 2025 at 3:52 AM
Harvard has set an example for other higher-ed institutions - rejecting an unlawful and ham-handed attempt to stifle academic freedom, while taking steps to make sure students can benefit from an environment of intellectual inquiry, rigorous debate and mutual respect. Let’s hope others follow suit.
Reposted by Bujamin Vokshi
I signed this.
Now, more than ever, the #global #science community needs to stand together - #united against those who attack science 🧪, who seek to diminish #scientists, who destroy critical programs that advance #equality, #diversity and #inclusion
Please consider to join us in signing the #MilanDeclaration ⏬
Please consider to join us in signing the #MilanDeclaration ⏬
March 5, 2025 at 1:55 PM
I signed this.
Extremely honoured to be the 2025 recipient of the Francois Wallace Monahan fellowship supporting my next 2 years of research on lung cancer metastasis in the Massagué group at MSK.
February 8, 2025 at 2:09 AM
Extremely honoured to be the 2025 recipient of the Francois Wallace Monahan fellowship supporting my next 2 years of research on lung cancer metastasis in the Massagué group at MSK.
Must read. Fantastic work that uncovered a novel immune checkpoint associated with cellular senescence. Congrats Charlène and the amazing team!
I am thrilled to share that my PhD research project has just been published in @natureportfolio.bsky.social #NatureAging !
We discovered how senescent cells use the ganglioside GD3 as a Senescence Immune Checkpoint to escape immune clearance. #NKcells #Siglec7
www.nature.com/articles/s43...
We discovered how senescent cells use the ganglioside GD3 as a Senescence Immune Checkpoint to escape immune clearance. #NKcells #Siglec7
www.nature.com/articles/s43...
A ganglioside-based immune checkpoint enables senescent cells to evade immunosurveillance during aging - Nature Aging
This study identifies a novel immune checkpoint in senescent cells that is linked to the ganglioside GD3 and that contributes to the evasion of immune clearance by these cells and to aging and age-rel...
www.nature.com
January 2, 2025 at 11:15 PM
Must read. Fantastic work that uncovered a novel immune checkpoint associated with cellular senescence. Congrats Charlène and the amazing team!
Reposted by Bujamin Vokshi
Happy to share our perspective article about HER2low subtype and endocrine therapy resistance is online! www.frontiersin.org/journals/onc...
Frontiers | The intersection of the HER2-low subtype with endocrine resistance: the role of interconnected signaling pathways
www.frontiersin.org
November 22, 2024 at 2:12 PM
Happy to share our perspective article about HER2low subtype and endocrine therapy resistance is online! www.frontiersin.org/journals/onc...